10-K Decoder · All companies

GeneDx Holdings Corp.

WGS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$428M$305M+40.0%
Operating income−$13.1M−$23.2M+43.6%
Net income−$21.0M−$52.3M+59.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$123M$117M+5.5%
Operating income−$10.4M−$3.30M−215%
Net income−$12.3M−$7.60M−61.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was GeneDx's revenue in FY2025?
$428M in FY2025 (Fiscal year ended Dec 31, 2025), +40.0% vs $305M a year earlier, per its 10-K filed Feb 2026.
Was GeneDx profitable in FY2025?
No: net income was −$21.0M and operating income −$13.1M in FY2025.
What was GeneDx's revenue in Q3 2026?
$123M (+5.5% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.